Trident Texofab standalone net profit rises 3800.00% in the September 2022 quarter
Sales rise 14.93% to Rs 24.17 crore
Net profit of Trident Texofab rose 3800.00% to Rs 0.78 crore in the quarter ended September 2022 as against Rs 0.02 crore during the previous quarter ended September 2021. Sales rose 14.93% to Rs 24.17 crore in the quarter ended September 2022 as against Rs 21.03 crore during the previous quarter ended September 2021. ParticularsQuarter EndedSep. 2022Sep. 2021% Var.Sales24.1721.03 15 OPM %8.906.37 -PBDT1.450.69 110 PBT1.030.30 243 NP0.780.02 3800Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Oct 11 2022 | 2:09 PM IST